MURRIETA, Calif. The CHU de Quebec, one of the most important healthcare institutions in the province of Quebec and one of the biggest in Canada, and COPAN Diagnostics, Inc., announced today the full installation of WASPLab, the latest generation of full laboratory automation and digital microbiology system in Hopital de l'Enfant-Jesus, one of the five hospitals forming the CHU de Quebec. This hospital and COPAN group worked closely and collaboratively to deliver North America's fastest seamless solution for full laboratory automation. This is a historic first installation of a full laboratory automation and digital bacteriology system operational in North America. The installation of WASPLab's hardware took place in an unprecedented time of less than a week. The speed of installation means that disruption to the routine laboratory operations is minimal and Go-Live time after install is dramatically shortened.

"The Hopital de l'Enfant-Jesus is the first healthcare services provider to install and implement WASPLab in North America. This technology allows us to be more effective and efficient in our lab, which is very important from a budget point of view. It also allows us to face the shortage of qualified staff and appoint them to value-added tasks. Like most microbiology labs, we have a limited amount of space but with COPAN's WASPLab solution however, it allows us to bring in the latest technology for specimen processing, robotics, image analysis and digital reporting without having to tear down our lab," said Jean-Francois Gagnon, Microbiology Laboratory Manager at Hopital de l'Enfant-Jesus..

"COPAN values the close and collaborative relationships that enable us to innovate together by understanding our customers' needs and delivering solutions that achieve their highest goals for improving the ultimate quality of patient care," said Norman Sharples, CEO of COPAN Diagnostics, Inc. "WASPLab moves microbiology from what was essentially a batch process to an efficient and continuous automated flow from sample processing to incubation, reading, interpretation, work-up and reporting," added Sharples.

"WASPLab solution allows standardization of the planting and streaking and specimen processing, decreases risk of errors, and also lowers repetitive stress related to repeated movement for our staff" said Dr. Alain Paradis, Chief Microbiologist and Infectious Disease Specialist for Hopital de l'Enfant-Jesus, CHU de Quebec.

"We are excited to partner with the CHU de Quebec to help them achieve their goals. WASPLab's modular design and small footprint allowed us to customize it to Hopital de l'Enfant-Jesus needs in terms of technology and laboratory space constraints. WASPLab's small, high efficiency footprint eliminates unnecessary track that increases speed of positive culture plate availability, saves costs, reduces maintenance and avoids the artificial barriers extensive track creates within the lab," concluded Sharples.

COPAN will showcase WASPLab during AACC Clinical Lab Expo in Houston, Texas in July 2013.

About the CHU de Quebec Consist of the CHUL, L'Hotel-Dieu de Quebec and hospitals l'Enfant-Jesus, Saint-Francois d'Assise and du Saint-Sacrement, the CHU de Quebec is the most important health care institution in the province of Quebec and one of the biggest in Canada. The CHU de Quebec offers general and specialized care, but mostly ultra-specialized care throughout Eastern Quebec, which represents nearly two million persons. In partnership with Universite Laval and focused on the future, the CHU de Quebec also has core missions in teaching, in research in many fields of excellence, and in the evaluation of health technologies and professional practices.14,000 employees, 1,700 doctors, dentists and pharmacists, and also 500 researchers are needed to accomplish those missions.

About Copan Diagnostics, Inc. With a reputation for innovation, Copan is the leading manufacturer of collection and transport systems in the world. Copan's collaborative approach to preanalytics has resulted in Flocked Swabs, ESwab, Universal Transport Medium and modular laboratory automation, WASP and WASPLab. For more information about Copan Diagnostics, visit http://www.copanusa.com.

SOURCE Copan Diagnostics, Inc.

CONTACT: Gabriela Franco, Director of Marketing, (800) 216-4016, Gabriela.franco@copanusa.net

Read the rest here:
The CHU de Quebec and COPAN Achieve Landmark First Installation in North America of Next ...

Public release date: 2-Jul-2013 [ | E-mail | Share ]

Contact: Jim Sliwa jsliwa@asmusa.org 202-942-9297 American Society for Microbiology

The strain of cholera that has sickened thousands in Haiti came from a single source and was not repeatedly introduced to the island over the past three years as some have thought, according to a new study published in mBio, the online open-access journal of the American Society for Microbiology.

The results of this latest study are consistent with earlier findings that indicate Vibrio cholerae bacteria were introduced to Haiti by United nations soldiers between July and October 2010, when Nepalese soldiers arrived to assist recovery efforts after the January 2010 earthquake in that country. The genome sequences of V. cholerae strains from Haiti reveal they have not gained any new genetic material since their introduction and that they have a limited ability to acquire genes from other organisms through a process called transformation.

This new information may help public health authorities understand future cholera outbreaks in Haiti and elsewhere, according to the authors. "The use of high resolution sequence data that is amenable to evolutionary analysis will greatly enhance our ability to discern transmission pathways of virulent clones such as the one implicated in this epidemic," write the authors.

The earthquake in January 2010 killed tens of thousands of Haitians, and it was followed several months later by an outbreak of cholera, a disease that had never before been documented in Haiti. Studies of the outbreak indicate that poor sanitation at a United Nations camp resulted in sewage contamination of local water supplies, and phylogenetic analysis of the Haiti V. cholerae strains and strains from around the globe indicate the strain was most likely accidentally brought to the camp by U.N. troops from Nepal.

Earlier "fingerprinting" of Haiti's V. cholerae isolates using pulse-field gel electrophoresis (PFGE) has shown the bacterium has changed somewhat since the epidemic began in October 2010, but because of the nature of PFGE, the significance of those changes was not known. Were the changes meaningful? Were the bacteria gaining or losing genes that could impact the course of disease? Did they gain genes from other bacteria in the environment? Are their genomes rearranged? The answers could make a difference in the severity of future outbreaks.

The authors of the study in mBio set out to study in greater detail how V. cholerae may have evolved since its introduction to the island nation, and whether it has acquired genes that bestow new abilities. They sequenced the genomes of 23 different V. cholerae isolates from Haiti that represent multiple PFGE "fingerprint" patterns and were taken from a variety of locations and at various time points during the epidemic.

When compared with the genome sequences of V. cholerae strains from around the world, the Haiti isolates and three Nepal isolates are tightly related, forming a monophyletic group to which no other genome sequences belong.

This result indicates that "Nepalese isolates are the closest relatives to the Haiti strain identified to date, even when placed into a phylogeny with a larger collection of isolates representing recent cholera epidemics," write the authors. This means that the outbreak originated from a single introduction of bacteria, and PFGE variants arose from gradual evolution of the organisms, not from any secondary introduction.

See the rest here:
Genomes of cholera bacteria from Haiti confirm epidemic originated from single source

Unknown 2,microbiology

By: bricallia jubi

Read more:
Unknown 2,microbiology - Video